NCT00885105View on ClinicalTrials.gov

Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age

PHASE3CompletedINTERVENTIONAL

Enrollment

242

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

September 30, 2007

Conditions

Influenza

Interventions

BIOLOGICAL

Influenza Virus Vaccine

0.25 mL, Intramuscular

BIOLOGICAL

Influenza Virus Vaccine

0.25 mL, Intramuscular

Trial Locations (6)

15241

Pittsburgh

27704

Durham

30062

Marietta

45404

Dayton

72205

Little Rock

98040

Seattle

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00885105 - Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age | Biotech Hunter | Biotech Hunter